在帕金森病中失调的凝血
Xinqing Wang1, Wenxin Li2, Xinyue Zhao2
1School of Public Health, Hengyang Medical School, University of South China, Hengyang 421001, China.
Cells
|November 27, 2024
概括
帕金森病 (PD) 与血液凝固问题有关,PD患者患血栓的风险更高. 了解这种联系可能会揭示这种神经退行性疾病的新疗法.
科学领域:
- 神经科学是一个神经科学.
- 血液学 血液学 血液学
背景情况:
- 帕金森病 (PD) 涉及神经退行和α-synuclein积累.
- 凝血功能障碍越来越多地被认为是PD的一个因素.
研究的目的:
- 审查新出现的证据,将凝血失调与PD病理生理学联系起来.
- 探索潜在的机制和未来的研究方向.
主要方法:
- 对PD中的凝血参数进行当前研究的综合.
- 对PD患者血栓事件的流行病学数据的检查.
- 分析炎症和氧化应激的作用.
主要成果:
- 患有PD的患者表现出凝血发生变化:纤维素因子升高,纤维素分解受损,血小板功能障碍.
- 在PD中观察到高凝血状态.
- 在PD患者中增加深静脉血栓症 (DVT) 和中风的发生率.
结论:
- 失调的凝血与帕金森病有显著的关联.
- 炎症和氧化应激可以调解凝血和神经退行之间的联系.
- 对凝血-神经退行轴的进一步研究对于新的PD诊断和治疗方法至关重要.
相关概念视频
Parkinson's Disease: Treatment
220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Disorders of Hemostasis
710
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
710
Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Extrinsic and Intrinsic Pathways of Hemostasis
5.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.6K


